Leading an initiative such as this one, which is based on a good platform of research, it, contemporary infrastructure, and nationwide collaboration in biomedical sciences, is totally aligned with the strategic strategy of the study Institute of the MUHC. A public-private consortium involving the Canadian Institutes of Health Research and several large pharmaceutical companies is supporting this study and facilitating the transfer of understanding, from results to actual patient remedies, underscores the importance of this research, notes Dr. Bourbeau. It is urgent that we utilize the tools of modern medicine to change the span of this devastating disease, which has far too much stigma attached to it still.It provided guidance to congressional leaders on the appropriate language regarding ACOs and lobbied aggressively for its inclusion. Within its continuing attempts, the association is definitely hosting a series of meetings this year 2010 that gather the leaders of healthcare delivery systems to educate medical group leaders on how best to develop, operate, and maintain high-performing ACOs. The meetings concentrate on physician-led, patient-centered ACOs and exceed the theoretical by bringing together actual case studies provided by the medical group leaders with firsthand encounter in providing accountable treatment to their patients.